unknown
Stage
2020
Founded
1
Investors
About
GateHouse Bio develops RNA-targeting therapeutics using proprietary small RNA technology to address genetic diseases.
Explore GateHouse Bio (fka sRNAlytics)'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.